All eyes on COVID-19 vaccine — PM Modi holds talks with three more teams involved in developing the vaccine
PM Modispoke to Gennova Biopharma, Biological E, and Dr Reddy’s.
- While Gennova Bipharma and Biological E are working on their own vaccines, Dr Reddy's has tied up with Russia to conduct trials of the Sputnik V vaccine.
- He had earlier visited the top three contenders – Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad, and the Serum Institute of India in Pune.
He spoke to Gennova Biopharma, Biological E and Dr Reddy’s today (November 30). While Gennova Bipharma and Biological E are working on their own vaccines, Dr Reddy's has tied up with Russia to conduct trials of the Sputnik V vaccine.
A statement from the Prime Minister's Office said that Modi also asked the companies, represented by these teams, to come out with their suggestions and ideas regarding the regulatory processes and related matters. "The PM advised all the departments concerned to engage with the manufacturers and seek to resolve matters so that the efforts by these companies bear fruit in order to serve the needs of the country and the entire world," it added.
On November 28, Modi went on a three-city tour for an extensive review of the vaccine development and manufacturing process, which involved visits to the top three contenders – Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad, and the Serum Institute of India in Pune.
Had a good interaction with the team at Serum Institute of India. They shared details about their progress so far o… https://t.co/HbzIG4Caiv— Narendra Modi (@narendramodi) 1606568703000
After Modi’s visit, IANS quoted an SII official to say that the government is hoping for 300-400 million doses of coronavirus vaccine by July 2021. “Presently, we have nothing in writing from the government on how many doses it will buy, but the indication is that the need would be for around 300-400 million doses by July 2021," said Adar Poonawalla, after the Prime Minister’s visit.
At the Bharat Biotech facility in Hyderabad, was briefed about their indigenous COVID-19 vaccine. Congratulated the… https://t.co/ERQxcjRzWg— Narendra Modi (@narendramodi) 1606555791000
Visited the Zydus Biotech Park in Ahmedabad to know more about the indigenous DNA based vaccine being developed by… https://t.co/ADunxDQnrk— Narendra Modi (@narendramodi) 1606547177000
Modi’s vaccine visit was praised by many, including opposition leaders of the Congress, who believed that the Prime Minister’s presence would have given a boost to the manufacturers.
Earlier, the Indian government announced a ₹900 crore fund dedicated to the research, and development of COVID-19 vaccine. ““India is waiting for an effective vaccine to come - one or many more. We are spending on research and development apart from what we will give when the vaccine is ready to be bought and distributed. We are also keeping abreast of the developments around the vaccine,” Finance Minister Nirmala Sitharaman had said while announcing the fund.
- Micron begins construction on $2.7 bn India semiconductor plant in 'epic' beginning
- India, Japan agree to strengthen economic cooperation including achieving progress on high-speed railway project
- India rises to No 1 in ODIs, becomes top ranked team in all formats
- Discover what's new in iOS 17: Your ultimate guide to the latest features
- Hyderabad-based ethnic retailer Sai Silks Kalamandir IPO subscribed 4.4x